Aquestive Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. 

CEO
Daniel Barber
CEODaniel Barber
Employees
147
Employees147
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2004
Founded2004
Employees
147
Employees147

AQST Key Statistics

Market cap
579.87M
Market cap579.87M
Price-Earnings ratio
-7.13
Price-Earnings ratio-7.13
Dividend yield
—
Dividend yield—
Average volume
2.32M
Average volume2.32M
High today
$4.81
High today$4.81
Low today
$4.61
Low today$4.61
Open price
$4.72
Open price$4.72
Volume
2.41M
Volume2.41M
52 Week high
$7.55
52 Week high$7.55
52 Week low
$2.93
52 Week low$2.93

Stock Snapshot

With a market cap of 579.87M, Aquestive Therapeutics(AQST) trades at $4.62. The stock has a price-to-earnings ratio of -7.13.

During the trading session on 2026-10-01, Aquestive Therapeutics(AQST) shares reached a daily high of $4.81 and a low of $4.61. At a current price of $4.62, the stock is +0.1% higher than the low and still -4.0% under the high.

Trading volume for Aquestive Therapeutics(AQST) stock has reached 2.41M, versus its average volume of 2.32M.

The stock's 52-week range extends from a low of $2.93 to a high of $7.55.

The stock's 52-week range extends from a low of $2.93 to a high of $7.55.

AQST News

TipRanks 2d
Aquestive Therapeutics Adds Veteran Executive to Board

Aquestive Therapeutics ( (AQST) ) has provided an update. On September 29, 2026, Aquestive Therapeutics announced that its board had elected veteran life scien...

TipRanks 2d
Aquestive Therapeutics appoints Daly to board of directors

Aquestive Therapeutics (AQST) announced the appointment of Rich Daly to the Company’s Board of Directors, effective October 14, 2026. Following Mr. Daly’s appoi...

TipRanks 6d
Aquestive updates investor presentation on pipeline and regulation

Aquestive Therapeutics ( (AQST) ) has shared an update. Aquestive Therapeutics has released an updated corporate investor presentation dated September 23, 2026...

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AQST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.